We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Gallbladder Removed via Single Port Access

By HospiMedica staff writers
Posted on 29 May 2007
In a first-of-its-kind procedure, a surgeon successfully removed a woman's gallbladder through a single incision in the patient's belly button.

The single port access (SPA) surgery was performed using RealHand high dexterity (HD) instrumentation. More...
RealHand instruments claim to be the first full range of motion hand-held laparoscopic instruments. Developed with the EndoLink mechanism, RealHand technology is designed to mirror the surgeon's hand direction with the added benefit of tactile feedback; when the surgeon's hand moves in one direction, the instrument tip exactly follows. RealHand instruments offer complete 7° of freedom of movement in a hand-held instrument, with no need for additional hardware.

RealHand instruments, developed by Novare Surgical Systems (Cupertino, CA, USA), could enable surgeons to perform more difficult maneuvers that cannot be completed with traditional rigid instruments. The increase in range of motion should lead the way for development of new surgical approaches and techniques. RealHand instruments have been approved by the U.S. Food and Drug Administration (FDA).

The surgical procedure was performed by Paul G. Curcillo II, M.D. FACS, an associate professor and vice-chair of the department of surgery at Drexel University College of Medicine (Philadelphia, PA, USA; www.drexelmed.edu), and director of the robotic and minimally invasive surgery section.

"We are now able to decrease the number of incisions required in routine laparoscopy, as well as do more advanced procedures through the laparoscope,” said Dr. Curcillo. "Fewer incisions are ultimately better for the patient in terms of the amount of discomfort and recovery time, not to mention the benefit of a hidden scar. Most important, this technique can be easily learned by surgeons and gynecologists currently doing laparoscopy.”

Dr. Curcillo's procedure is similar in principal to natural orifice transluminal endoscopic surgery (NOTES) in which surgeons enter through the mouth, rectum, or vagina in an attempt to minimize scarring and port access through the abdomen.


Related Links:
Novare Surgical Systems
Drexel University College of Medicine

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.